The Ottawa Hospital
Welcome,         Profile    Billing    Logout  
 379 Trials 
1426 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goel, Rakesh
ELAINE 3, NCT05696626: Evaluation of Lasofoxifene Combined with Abemaciclib Compared with Fulvestrant Combined with Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation

Recruiting
3
500
Europe, Canada, US, RoW
Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib
Sermonix Pharmaceuticals Inc.
Metastatic Breast Cancer
04/27
04/28
COBRA, NCT04068103: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Active, not recruiting
2/3
1408
Canada, US
Capecitabine, Ro 09-1978/000, Xeloda, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Leucovorin, Folinic acid, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, citrovorum factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Oxaliplatin, 1-OHP, Ai Heng, Aiheng, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Patient Observation, Active Surveillance, deferred therapy, expectant management, observation, Watchful Waiting
NRG Oncology, National Cancer Institute (NCI)
Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8
06/23
04/27
CIRCULATE-US, NCT05174169: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Recruiting
2/3
1912
Canada, US
Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month, mFOLFIRINOX, mFOLFOX6 6 month, CAPOX 6 month
NRG Oncology, Natera, Inc., National Cancer Institute (NCI)
Stage III Colon Cancer
03/29
03/30
Laurie, Scott A
CCTG IND.238A, NCT03847649: A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

Recruiting
2
60
Canada
Durvalumab, Prednisone, Tremelimumab
Canadian Cancer Trials Group, AstraZeneca
Cancer
04/30
04/31
TWT-101, NCT04521413: Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

Recruiting
1/2
170
Canada, US, RoW
CFI-402411, 2411, 402411, Pembrolizumab, Keytruda, pembro
Treadwell Therapeutics, Inc, TIO Discovery Engine
Advanced Solid Malignancies
11/24
12/24
NCT03990454: Safety Study of SLC-391 in Subjects With Solid Tumors

Completed
1
35
Canada
SLC-391
SignalChem Lifesciences Corporation
Solid Tumor
06/23
06/23
NCT06384352: A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

Recruiting
1
155
Canada, US, RoW
YL211
MediLink Therapeutics (Suzhou) Co., Ltd., Hoffmann-La Roche
Advanced Solid Tumors
04/27
04/29
NCT04446351: Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors

Recruiting
1
244
Canada, Japan, US, RoW
GSK6097608, Dostarlimab, Cobolimab, Belrestotug, GSK4428859A, EOS884448
GlaxoSmithKline, 23andMe, Inc., iTeos Therapeutics
Neoplasms
09/25
09/25
Clemons, Mark J
REaCT-ZOL, NCT03664687: Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer

Active, not recruiting
4
211
Canada
Zoledronate, Zoledronic acid
Ottawa Hospital Research Institute
Early-stage Breast Cancer
04/20
12/24
NCT05365230: A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

Active, not recruiting
4
264
Canada
On-demand personalized follow-up care, Guideline-based follow-up care (standard of care)
Ottawa Hospital Research Institute
Breast Cancer
07/26
07/26
Arnold, Jennifer
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Active, not recruiting
4
446
Europe, Canada, US, RoW
Faricimab
McMaster University, Hoffmann-La Roche
Diabetic Macular Edema
12/26
12/26
PREFERRED-1, NCT05096195: PRevEnting FracturEs in REnal Disease 1

Active, not recruiting
4
60
Canada
Denosumab 60 mg/ml, Prolia, Calcium and vitamin D prophylaxis, Monitoring of post-injection calcium and phosphate
Western University, Canada, ICES, Academic Medical Organization of Southwestern Ontario, Western University, The Kidney Foundation of Canada
Kidney Diseases, Dialysis; Complications, Fragility Fracture, Chronic Kidney Disease-Mineral and Bone Disorder
12/25
12/25
NCT05686044: A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

Completed
2/3
320
US
Buntanetap/Posiphen, Posiphen Tartrate, Placebo
Annovis Bio Inc.
Alzheimer Disease
02/24
02/24
REPAIR-MDS, NCT04997811: Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes

Recruiting
2
120
Europe
Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol
Prof. Janet Dunn, Blood Cancer UK, Dudley Group NHS Foundation Trust, University of Birmingham, University of Manchester, King's College Hospital NHS Trust
Myelodysplastic Syndromes (MDS)
01/25
06/25
NCT06701721: A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.

Recruiting
1
21
RoW
THN391 MAD
Therini Bio Pty Ltd
Diabetic Macular Edema, Diabetic Retinopathy
10/25
02/26
Cheung, Angela M
NCT01896011: Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures

Completed
3
34
Canada
Teriparatide 20 mcg, Brand name Forteo, Placebo
University Health Network, Toronto, The Physicians' Services Incorporated Foundation, Eli Lilly and Company
Non Displaced Atypical Femoral Fractures
12/21
12/22
PRECIOSA, NCT03451292 / 2016-001789-28: Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites

Completed
3
410
Europe, Canada, US, RoW
Albutein 20% Injectable Solution, Standard medical treatment
Grifols Therapeutics LLC, Instituto Grifols, S.A.
Decompensated Cirrhosis and Ascites
05/24
05/24
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Active, not recruiting
3
238
Europe, Canada, Japan, US, RoW
Linerixibat, Placebo
GlaxoSmithKline
Pruritus
10/24
01/25
ESSOR, NCT05999435: Study of LAU-7b for the Treatment of Long COVID in Adults

Active, not recruiting
2/3
272
Canada
LAU-7b for 3 cycles, fenretinide, LAU-7b for 1 cycle, then placebo, Placebo for 3 cycles, sugar pill
Laurent Pharmaceuticals Inc.
Long COVID
08/24
10/24
RECLAIM - HBOT, NCT06452095: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition

Not yet recruiting
2/3
120
NA
Hyperbaric Oxygen therapy
University Health Network, Toronto
Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19
12/28
12/28
RECLAIM, NCT05513560: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

Active, not recruiting
2/3
460
Canada
Ibudilast, MN-166, Pentoxifylline, Placebo
University Health Network, Toronto
Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19
03/25
03/25
VISTAS, NCT04663308 / 2020-003027-41: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Recruiting
2
200
Europe, Canada, US, RoW
Volixibat, SHP626, Placebo
Mirum Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc.
Primary Sclerosing Cholangitis
09/25
12/25
Hi-OXSR, NCT06379620: Pilot Open Label Use of the for the Treatment of Post COVID-19 Cognitive Dysfunction

Completed
1
37
Canada
Hi-OxSR Sequential Rebreathing mask (oxygen concentrator)
University Health Network, Toronto
Post COVID-19 Condition
03/24
03/24
NCT05231668: Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Terminated
1
16
Europe, Canada, US, RoW
SAR439459, Placebo
Sanofi
Osteogenesis Imperfecta
11/24
11/24
NCT01155245: Teriparatide (PTH) and Bone Strength in Postmenopausal Women

Active, not recruiting
N/A
60
Canada
Forteo
University Health Network, Toronto, Eli Lilly and Company
Osteoporosis
01/24
01/25
NCT01747304: Evaluation of IVA (SE Femur Scans) to Identify Incomplete AFFs

Recruiting
N/A
500
Canada
DXA Se femur scans (previously called IVA femur), SF Femur scans
University Health Network, Toronto
Atypical Femur Fracture
12/24
12/25
NCT01155232: Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis

Recruiting
N/A
100
Canada
Teriparatide, Teriparatide is a section of the parathyroid hormone (PTH) given by injection., The drug is marketed by Eli Lilly under the name of Forteo
University Health Network, Toronto
Osteoporosis
01/25
01/26
NCT01747291: Atypical Fracture Cohort Study

Recruiting
N/A
300
Canada
University Health Network, Toronto
Atypical Femur Fracture, Atypical Subtrochanteric Fracture, Osteoporosis With AFf
12/25
12/26
NCT04110795: Personalizing Osteoporosis Care: Clinical & Genetic Risk Factors for AFFs

Active, not recruiting
N/A
1200
Canada
No Intervention
University Health Network, Toronto, Canadian Institutes of Health Research (CIHR)
Atypical Femur Fracture
12/25
12/27
NCT05541432: Finding the Optimal Resistance Training Intensity For Your Bones

Recruiting
N/A
324
Canada
Supervised strength training (group 1), Supervised strength training (group 2), Home exercise
University of Waterloo, Canadian Institutes of Health Research (CIHR), University of Saskatchewan, University Health Network, Toronto
Osteoporosis, Osteopenia
09/26
09/26
CaNAL, NCT03569826: Canadian Network for Autoimmune Liver Disease

Recruiting
N/A
2500
Canada
Observational; no intervention
University Health Network, Toronto
Primary Bilary Cirrhosis (PBC), Autoimmune Hepatitis, Overlap Syndrome
12/28
12/28
Angel, Jonathan B
CINNAMON, NCT06039579: Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

Completed
2
44
Europe, Canada, US, RoW
VH4004280, VH4011499, VH4004280 Matching Placebo, VH4011499 Matching Placebo
ViiV Healthcare
HIV Infections
06/24
06/24
Cameron, William
NCT04773665: Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

Completed
1
114
Canada
VBI-2902a, Placebo, VBI-2905a
VBI Vaccines Inc.
Covid19
11/22
11/22
NCT05548439: Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

Active, not recruiting
1
103
Canada
VBI-2901a
VBI Vaccines Inc.
COVID-19, Coronavirus Infections
02/24
02/24
NCT05614245: Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant

Withdrawn
1
60
Canada
VBI-2901e
VBI Vaccines Inc.
COVID-19, Coronavirus Infections
06/24
06/24
Stiell, Ian
RAFF4, NCT04485195: Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

Recruiting
4
340
Canada
Vernakalant, BRINAVESS, Procainamide
Ottawa Hospital Research Institute
Atrial Fibrillation
09/23
06/24
RAFF5, NCT05468281: Proposal: Improve the Quality and Safety of Patients Seen in the Emergency Department for Acute Atrial Fibrillation and Flutter

Completed
N/A
1108
Canada
Checklist implementation
Ottawa Hospital Research Institute
Atrial Fibrillation, Atrial Flutter
07/23
07/23
Knoll, Greg A
NCT03206801: Urine CXCL10 Monitoring Trial in Kidney Transplant

Active, not recruiting
2/3
420
Canada, RoW
Kidney transplant biopsy, Protocol biopsy
University of Manitoba, Canadian Institutes of Health Research (CIHR), Canadian National Transplant Research Program
Kidney Transplant; Complications, Rejection of Renal Transplant
06/24
09/25
CARSK, NCT03674307: Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

Recruiting
N/A
3306
Europe, Canada, US
No screening, Regular Screening
University of British Columbia, University of Sydney
Cardiovascular Diseases, End Stage Renal Disease, Kidney Transplantation, Dialysis Related Complication
12/25
12/25
Patel, Rakesh
NCT04511702: Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate

Completed
4
191
US
Pegloticase with MTX, Methotrexate
Amgen
Chronic Uncontrolled Gout, Gout, Uncontrolled Gout
01/24
03/24
TOGETHER-PsA, NCT06588296: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

Recruiting
3
250
US
Ixekizumab, LY2439821, Tirzepatide, LY3298176
Eli Lilly and Company
Psoriatic Arthritis, Obesity
04/26
08/26
TOPAZ-1, NCT04895241 / 2020-005775-12: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Checkmark Trial initiation of TOPAZ-1 trial in lupus
Jun 2021 - Jun 2021: Trial initiation of TOPAZ-1 trial in lupus
Recruiting
3
540
Europe, US, RoW
Litifilimab, BIIB059, Placebo
Biogen
Lupus Erythematosus, Systemic
09/26
03/27
NEPTUNUS-2, NCT05349214 / 2021-005687-22: Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

Active, not recruiting
3
505
Europe, Canada, Japan, US, RoW
VAY736, Placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Sjogren Syndrome
05/25
05/27
NCT06104124: A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Recruiting
3
621
Europe, Canada, Japan, US, RoW
Dazodalibep, VIB 4920, MEDI 4920, Placebo
Amgen
Sjogren's Syndrome
08/26
08/26
NEPTUNUS-Ext, NCT05985915: A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Recruiting
3
600
Europe, Canada, Japan, US, RoW
Ianalumab (VAY736), VAY736, Placebo
Novartis Pharmaceuticals
Sjogrens Syndrome
08/28
07/30
NCT05848258: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

Recruiting
2
380
Europe, US, RoW
LY3871801, Placebo
Eli Lilly and Company, Rigel Pharmaceuticals
Rheumatoid Arthritis
02/26
07/26
NCT02926924: Prophylactic Application of an Incisional Wound Vac to Prevent Wound Complications in Obese Spine Surgery Patients

Recruiting
N/A
150
US
Wound Vac, Negative pressure therapy, Standard Dressing
University of Michigan
Spine Surgery, Wounds Vac
04/23
04/23
NCT06217380: Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program

Terminated
N/A
10
Canada
Masimo SafetyNet Alert (MSNA)
Masimo Corporation
Opioid Use
02/24
02/24
JULI, NCT04726254: The Registry--Hemp and Cannabis Observational Registry

Recruiting
N/A
2000
US
Juva Life, Targeted Medical Education
Chronic Pain, Appetite Disorders, Neuropathy, Menopausal Syndrome, Anxiety, Sleep Disturbance, Nausea
02/24
02/25

Recruiting
N/A
3000
US
Treatment Recommendation Surveys, 7-gene biosignature
PreludeDx, University of South Florida
DCIS
12/25
12/35
NA-PAS, NCT04836546: Eversense® Non-adjunctive Use Post Approval Study

Recruiting
N/A
925
US
Blood glucose meter, Eversense CGM System
Senseonics, Inc.
Diabetes
03/26
03/26
RISC, NCT05848856: The Registry--Risk Informed Screening Registry

Not yet recruiting
N/A
10000
US
Breast Cancer, Cardiometabolic, Cardiovascular Risk Screening and Follow up
Precision Health Equity Initiative
Breast Cancer Risk, Cardiovascular Disease Risk, Cardiometabolic Risk, Diabetes
09/34
09/35
Kim, Paul R
NCT03102125: Allograft Dysfunction in Heart Transplant

Recruiting
4
376
US
Regadenoson, Lexiscan
Paul Kim
Heart Transplant Failure and Rejection
12/25
12/25
PE-TRACT, NCT05591118: Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Recruiting
3
500
US
Anticoagulant Therapy, Catheter-Directed Therapy
NYU Langone Health, National Heart, Lung, and Blood Institute (NHLBI)
Pulmonary Embolism
01/27
01/28
NCT05417074: Assessing SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Not yet recruiting
2
10
US
Placebo, SLS-002, Intranasal Racemic Ketamine, Standard of care
Johns Hopkins University, Seelos Therapeutics, Inc.
Depression, Suicidal Behavior, Suicidal Ideation
03/23
08/23
ELIMINATE, NCT05488340: A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli ( Trial)

Recruiting
2
318
US
LBP-EC01 0.1 x IV dose, 1x10^11 PFU IV dose, LBP-EC01 0.01x IV Dose, 1x10^10 PFU IV Dose, LBP-EC01 IV Infusion Dose, 1x10^12 PFU IV Infusion Dose, Placebo, LBP-EC01, TMP/SMX
Locus Biosciences, Parexel
Urinary Tract Infections
06/25
12/25
NCT03543007: Evaluating the Safety and Efficacy of GrafixPL™PRIME for the Treatment of Chronic Venous Leg Ulcers

Not yet recruiting
N/A
30
US
GrafixPL™ PRIME plus standard compression therapy, standard compression therapy alone
Georgetown University, Osiris Therapeutics
Venous Leg Ulcer, Chronic Leg Ulcer, Venous Insufficiency, Venous Stasis
09/22
01/23
3STLIF, NCT04823858: 3Spine Lumbar Fusion Real World Evidence Study

Recruiting
N/A
200
US
Lumbar Interbody Fusion
3Spine, MCRA
Lumbar Spine Degeneration
05/24
08/26
NCT04684901: Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures

Enrolling by invitation
N/A
50
US
AlloWrap® Amniotic Membrane
AlloSource
Cervical Stenosis, Spondylolisthesis, Cervical Radiculopathy, Cervical Disc Disorder
06/25
01/26
ACES-EMB, NCT06414603: A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

Recruiting
N/A
250
US
The Prospera™ Test
Natera, Inc.
Heart Transplant Failure and Rejection
12/24
12/25
DEFINE-HT, NCT05309382: Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

Completed
N/A
147
US
Prospera
Natera, Inc.
Heart Transplant
10/24
10/24
NCT01420237: Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study

Active, not recruiting
N/A
352
Europe, Canada, US
Restoration ADM X3 Device
Stryker Orthopaedics
Arthroplasty, Replacement, Hip
06/26
06/26
Lapner, Peter
NCT02143245: Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections

Active, not recruiting
N/A
118
Canada
Synovial Biopsy, Open Tissue Biopsy
Ottawa Hospital Research Institute
Total Shoulder Arthroplasty
12/22
12/27
NCT02060227: Approach to Shoulder Instability

Completed
N/A
78
Canada
Open Latarjet procedure, Arthroscopic Bankart repair
Ottawa Hospital Research Institute
Anterior Shoulder Instability
12/23
04/24
TSAvRSA, NCT04228419: TSA vs RSA in Glenohumeral Osteoarthritis

Recruiting
N/A
108
Canada
Total Shoulder Arthroplasty, Reverse Shoulder Arthroplasty
Ottawa Hospital Research Institute
Osteoarthritis of the Shoulder
01/25
12/28
SERVASA15, NCT05487274: TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion

Recruiting
N/A
108
Canada
Total Shoulder Arthroplasty + augmented glenoid component, Reverse Shoulder Arthroplasty
Ottawa Hospital Research Institute
Osteoarthritis Shoulder
03/26
12/29
UESOA, NCT04634773: Unravelling the Etiology of Shoulder Osteoarthritis

Active, not recruiting
N/A
60
Canada
Low-dose CT, T1Rho MRI, Motion Analysis
Ottawa Hospital Research Institute, University of Ottawa
Osteoarthritis of the Shoulder
12/26
12/27
NCT02966886: TSA Techniques in Glenohumeral OA

Recruiting
N/A
216
Canada
Eccentric Reaming, Augmented Glenoid Component Implantation, Posterior Glenoid Bone Grafting
Ottawa Hospital Research Institute
Osteoarthritis, Shoulder
12/27
12/28
Dervin, Geoffrey
NCT03564730: Staged Versus Simultaneous Bilateral Knee Arthroplasty

Active, not recruiting
N/A
224
Canada
Simultaneous Knee Arthroplasty (UKA), Staged Knee Arthroplasty (UKA)
Orthopaedic Innovation Centre
Knee Osteoarthritis
11/25
12/26
NCT00261066: Outcome Following Orthopaedic Surgery

Active, not recruiting
N/A
8439
Canada
Ottawa Hospital Research Institute
Osteoarthritis of Knee
06/26
06/26
Juni, Peter
RECLAIM, NCT05513560: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

Active, not recruiting
2/3
460
Canada
Ibudilast, MN-166, Pentoxifylline, Placebo
University Health Network, Toronto
Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19
03/25
03/25
Tinmouth, Alan
iTADS, NCT03344887: An Innovative Trial Assessing Donor Sex on Recipient Mortality

Active, not recruiting
4
8850
Canada
RBC Transfusion from male donor, RBC Transfusion from female donor
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Canadian Blood Services
Red Blood Cell Transfusion
01/21
12/22
PATH, NCT04448184: Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The III Trial)

Recruiting
3
662
Canada
Tranexamic Acid, SteriMax Inc., Cyclokapron®
Ottawa Hospital Research Institute, Alberta Cancer Foundation
Hematologic Neoplasms
02/27
02/27
Zimmerman, Deborah
NCT03787589: Exercise in Patients With End Stage Kidney Disease

Recruiting
N/A
90
Canada
Exercise Prescription
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR)
Renal Failure
01/25
09/25
Fergusson, Dean
iTADS, NCT03344887: An Innovative Trial Assessing Donor Sex on Recipient Mortality

Active, not recruiting
4
8850
Canada
RBC Transfusion from male donor, RBC Transfusion from female donor
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Canadian Blood Services
Red Blood Cell Transfusion
01/21
12/22
TRACTION, NCT04803747: A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery

Active, not recruiting
4
8440
Canada
Tranexamic acid (TXA), Placebo (0.9 % Saline)
University of Manitoba, Canadian Institutes of Health Research (CIHR), Health Sciences Centre Foundation, Manitoba, The Ottawa Hospital
Major Non-cardiac Surgeries
03/24
10/24
POISE, NCT04871412: The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III

Recruiting
3
20
Canada
Vitamin D3 Drops, Vitamin D, Coriolus Versicolor, Trident SAP 66:33 Lemon, Fish Oil, Probiotic Pro12, Probiotics, Provitalix Pure Whey Protein, Protein Powder, Theracurmin 2X, Curcumin, Green Tea Extract, EGCG, Nutrition Recommendations, Physical Activity Recommendations, Psychological Recommendations
Ottawa Hospital Research Institute, The Canadian College of Naturopathic Medicine, Lotte & John Hecht Memorial Foundation, The Centre for Health Innovation, University of Ottawa
Lung Cancer, Gastric Cancer, Esophageal Cancer
12/29
12/31
CIRCA-19 RCT, NCT04865107: Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial

Recruiting
2
54
Canada
UC-MSCs, Placebo
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR)
Covid19, Acute Respiratory Distress Syndrome
04/22
04/22
HEMOTION, NCT03260478: HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The Trial

Completed
N/A
742
Europe, Canada, RoW
Red Blood Cells Transfusion
CHU de Quebec-Universite Laval, Canadian Critical Care Trials Group, Canadian Traumatic Brain Injury Research Consortium, Canadian Institutes of Health Research (CIHR), Canadian Perioperative Anesthesia Clinical Trials (PACT) Group
Traumatic Brain Injury, Transfusion
10/23
02/24
Aaron, Shawn
APIC, NCT06552364: Air Pollution and Inhaled Corticosteroids in COPD

Not yet recruiting
4
48
NA
LABA+LAMA, Anoro Ellipta, LABA+LAMA+ICS, Trelegy Ellipta, Filtered Air, Diesel Exhaust, Traffic Related Air Pollution
University of British Columbia, University of Calgary, University of Ottawa, University of Manitoba, University of North Carolina, Chapel Hill
COPD
12/26
12/28
CanCOLD, NCT00920348: The Canadian Cohort Obstructive Lung Disease

Active, not recruiting
N/A
1500
Canada
McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR), GlaxoSmithKline, AstraZeneca, Pfizer, Boehringer Ingelheim, Novartis, Takeda, Merck Sharp & Dohme LLC, Almirall, SAS
COPD, Chronic Obstructive Pulmonary Disease
12/22
12/22
NCT05181670: The Canadian Respiratory Research Network Long COVID-19 Study

Enrolling by invitation
N/A
650
Canada
Sunnybrook Health Sciences Centre, Canadian Institutes of Health Research (CIHR)
SARS-CoV-2 Infection, Post-acute Sequelae of SARS-CoV-2
08/24
12/24
ISAR, NCT04045587: International Severe Asthma Registry: Canadian Cohort

Recruiting
N/A
714
Canada
University of British Columbia, University of Alberta, University of Toronto, Laval University, McGill University, Université de Sherbrooke, The Ottawa Hospital, Queen's University, University of Saskatchewan, Western University, Canada
Severe Asthma
12/27
12/28
UCAP2, NCT06392776: Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL

Recruiting
N/A
420
Canada
Early diagnosis and treatment
Ottawa Hospital Research Institute
COPD, Asthma
12/28
12/29
CLOUD, NCT06819969: The Canadian Lung Outcomes in Users of Vaping Devices Study

Not yet recruiting
N/A
500
Canada
University of British Columbia, BC Children's Hospital Research Institute, Providence Healthcare, British Columbia Cancer Agency, University of Alberta, McMaster University, University of Ottawa, Université de Sherbrooke, University of Toronto
Small Airways Diseases, Vaping, Vaping Related Disorder, Vaping Teens, Vaping Behavior
12/29
12/29
NCT05204888: MyAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Recruiting
N/A
642
Canada, US
myAirvo3, Pulse oximeter
Temple University, Fisher and Paykel Healthcare
COPD
01/27
03/27
NCT06014840: The UCAP 2 Pilot Study

Withdrawn
N/A
200
Canada
Assessment and Treatment provided to participant by a respirologist using evidence-based guidelines for asthma or COPD
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR)
COPD, Asthma
12/27
12/28
Vaillancourt, Christian
EpiDOSE, NCT03826524: Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Recruiting
4
3790
Canada
Epinephrine, Adrenaline
Unity Health Toronto, Canadian Institutes of Health Research (CIHR), Pfizer
Cardiac Arrest, Out-Of-Hospital, Sudden Cardiac Arrest, Ventricular Fibrillation, Ventricular Tachycardia-Pulseless
12/27
06/28
NCT03642587: Canadian Sudden Cardiac Arrest Network

Completed
N/A
82054
Canada
There is no intervention in this study.
Unity Health Toronto, University of Toronto, Sunnybrook Health Sciences Centre, Ottawa Hospital Research Institute, University of British Columbia, Providence Health & Services, McMaster University, Queen's University, Kingston, Ontario, Institute for Clinical Evaluative Sciences, Alberta Health services, University of Saskatchewan, Dalhousie University, University of Prince Edward Island, Memorial University of Newfoundland
Sudden Cardiac Death, Sudden Cardiac Arrest
03/23
06/23
NCT03894059: An Educational Program to Improve Cardiac Arrest Diagnostic Accuracy of Ambulance Telecommunicators

Active, not recruiting
N/A
12224
Canada
Educational Intervention
Ottawa Hospital Research Institute, Ontario Ministry of Health and Long Term Care, BC Emergency Health Services, Medacom Atlantic, Alberta Health services, Emergency Health Services Nova Scotia, Health PEI, Providence Health Care, British Columbia
Heart Arrest, Heart Arrest, Out-Of-Hospital, Cardiac Arrest, Death, Sudden, Cardiac, Cardiac Arrest, Sudden, Cardiopulmonary Arrest
12/25
12/25
Harrison, Denise
NCT00404898: NYU/Bellevue WTC Health Impacts Research Registry

Recruiting
N/A
16000
US
NYU Langone Health, National Institute for Occupational Safety and Health (NIOSH/CDC)
Exposure to World Trade Center Dust
09/26
09/26
Torres, Carlos
NCT05532787: Comparison of Accelerated Diagnostic Pathways for Acute Chest Pain in Emergency Departments in the United Arab Emirates

Recruiting
N/A
1200
RoW
Application of acute chest pain risk stratification scores (HEART and EDACS)
Zayed Military Hospital
Acute Coronary Syndrome, Chest Pain
02/23
03/23
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Completed
N/A
244
US
MiniMed 780G System
Medtronic Diabetes, Eli Lilly and Company
Type 1 Diabetes
01/24
01/24
NCT05224258: Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Completed
N/A
240
Canada, US, RoW
MiniMed 780G System
Medtronic Diabetes
Type 1 Diabetes
06/24
06/24
Ryan, Stephen E
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
BRIDGE, NCT05538663: Intravesical BCG vs GEMDOCE in NMIBC

Recruiting
3
870
US
Gemcitabine, GEMZAR, Docetaxel, Taxotere, Bacillus Calmette Guerin, BCG
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Non-muscle-invasive Bladder Cancer
11/29
10/30
StrokeVIS, NCT05809973: The Oslo Study of Visual Impairment After Stroke

Recruiting
N/A
120
Europe
VISA tool
Oslo University Hospital, University of Liverpool, University of South-Eastern Norway
Stroke, Acute
05/24
12/24

Recruiting
N/A
348
Europe, Canada, US, RoW
Embolization
Maastricht University
Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR)
06/26
06/29
Smith, Heather
ATS22, NCT04378790: A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Recruiting
3
544
US
Patching, Eye Patch, Glasses, Spectacles
Jaeb Center for Health Research, National Eye Institute (NEI), Pediatric Eye Disease Investigator Group
Amblyopia
05/28
05/28
WATCH, NCT04869774: Wound And Symptom Tracking After Colorectal Surgery Using How2trak

Not yet recruiting
N/A
80
NA
How2Trak mobile application
University of Ottawa, The Ottawa Hospital, Health Outcomes Worldwide
Surgical Site Infection, Mobile Applications, Surgery--Complications, Colorectal Surgery
11/21
02/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goel, Rakesh
ELAINE 3, NCT05696626: Evaluation of Lasofoxifene Combined with Abemaciclib Compared with Fulvestrant Combined with Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation

Recruiting
3
500
Europe, Canada, US, RoW
Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib
Sermonix Pharmaceuticals Inc.
Metastatic Breast Cancer
04/27
04/28
COBRA, NCT04068103: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Active, not recruiting
2/3
1408
Canada, US
Capecitabine, Ro 09-1978/000, Xeloda, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Leucovorin, Folinic acid, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, citrovorum factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Oxaliplatin, 1-OHP, Ai Heng, Aiheng, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Patient Observation, Active Surveillance, deferred therapy, expectant management, observation, Watchful Waiting
NRG Oncology, National Cancer Institute (NCI)
Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8
06/23
04/27
CIRCULATE-US, NCT05174169: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Recruiting
2/3
1912
Canada, US
Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month, mFOLFIRINOX, mFOLFOX6 6 month, CAPOX 6 month
NRG Oncology, Natera, Inc., National Cancer Institute (NCI)
Stage III Colon Cancer
03/29
03/30
Laurie, Scott A
CCTG IND.238A, NCT03847649: A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

Recruiting
2
60
Canada
Durvalumab, Prednisone, Tremelimumab
Canadian Cancer Trials Group, AstraZeneca
Cancer
04/30
04/31
TWT-101, NCT04521413: Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

Recruiting
1/2
170
Canada, US, RoW
CFI-402411, 2411, 402411, Pembrolizumab, Keytruda, pembro
Treadwell Therapeutics, Inc, TIO Discovery Engine
Advanced Solid Malignancies
11/24
12/24
NCT03990454: Safety Study of SLC-391 in Subjects With Solid Tumors

Completed
1
35
Canada
SLC-391
SignalChem Lifesciences Corporation
Solid Tumor
06/23
06/23
NCT06384352: A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

Recruiting
1
155
Canada, US, RoW
YL211
MediLink Therapeutics (Suzhou) Co., Ltd., Hoffmann-La Roche
Advanced Solid Tumors
04/27
04/29
NCT04446351: Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors

Recruiting
1
244
Canada, Japan, US, RoW
GSK6097608, Dostarlimab, Cobolimab, Belrestotug, GSK4428859A, EOS884448
GlaxoSmithKline, 23andMe, Inc., iTeos Therapeutics
Neoplasms
09/25
09/25
Clemons, Mark J
REaCT-ZOL, NCT03664687: Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer

Active, not recruiting
4
211
Canada
Zoledronate, Zoledronic acid
Ottawa Hospital Research Institute
Early-stage Breast Cancer
04/20
12/24
NCT05365230: A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

Active, not recruiting
4
264
Canada
On-demand personalized follow-up care, Guideline-based follow-up care (standard of care)
Ottawa Hospital Research Institute
Breast Cancer
07/26
07/26
Arnold, Jennifer
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Active, not recruiting
4
446
Europe, Canada, US, RoW
Faricimab
McMaster University, Hoffmann-La Roche
Diabetic Macular Edema
12/26
12/26
PREFERRED-1, NCT05096195: PRevEnting FracturEs in REnal Disease 1

Active, not recruiting
4
60
Canada
Denosumab 60 mg/ml, Prolia, Calcium and vitamin D prophylaxis, Monitoring of post-injection calcium and phosphate
Western University, Canada, ICES, Academic Medical Organization of Southwestern Ontario, Western University, The Kidney Foundation of Canada
Kidney Diseases, Dialysis; Complications, Fragility Fracture, Chronic Kidney Disease-Mineral and Bone Disorder
12/25
12/25
NCT05686044: A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

Completed
2/3
320
US
Buntanetap/Posiphen, Posiphen Tartrate, Placebo
Annovis Bio Inc.
Alzheimer Disease
02/24
02/24
REPAIR-MDS, NCT04997811: Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes

Recruiting
2
120
Europe
Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol
Prof. Janet Dunn, Blood Cancer UK, Dudley Group NHS Foundation Trust, University of Birmingham, University of Manchester, King's College Hospital NHS Trust
Myelodysplastic Syndromes (MDS)
01/25
06/25
NCT06701721: A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.

Recruiting
1
21
RoW
THN391 MAD
Therini Bio Pty Ltd
Diabetic Macular Edema, Diabetic Retinopathy
10/25
02/26
Cheung, Angela M
NCT01896011: Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures

Completed
3
34
Canada
Teriparatide 20 mcg, Brand name Forteo, Placebo
University Health Network, Toronto, The Physicians' Services Incorporated Foundation, Eli Lilly and Company
Non Displaced Atypical Femoral Fractures
12/21
12/22
PRECIOSA, NCT03451292 / 2016-001789-28: Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites

Completed
3
410
Europe, Canada, US, RoW
Albutein 20% Injectable Solution, Standard medical treatment
Grifols Therapeutics LLC, Instituto Grifols, S.A.
Decompensated Cirrhosis and Ascites
05/24
05/24
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Active, not recruiting
3
238
Europe, Canada, Japan, US, RoW
Linerixibat, Placebo
GlaxoSmithKline
Pruritus
10/24
01/25
ESSOR, NCT05999435: Study of LAU-7b for the Treatment of Long COVID in Adults

Active, not recruiting
2/3
272
Canada
LAU-7b for 3 cycles, fenretinide, LAU-7b for 1 cycle, then placebo, Placebo for 3 cycles, sugar pill
Laurent Pharmaceuticals Inc.
Long COVID
08/24
10/24
RECLAIM - HBOT, NCT06452095: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition

Not yet recruiting
2/3
120
NA
Hyperbaric Oxygen therapy
University Health Network, Toronto
Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19
12/28
12/28
RECLAIM, NCT05513560: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

Active, not recruiting
2/3
460
Canada
Ibudilast, MN-166, Pentoxifylline, Placebo
University Health Network, Toronto
Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19
03/25
03/25
VISTAS, NCT04663308 / 2020-003027-41: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Recruiting
2
200
Europe, Canada, US, RoW
Volixibat, SHP626, Placebo
Mirum Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc.
Primary Sclerosing Cholangitis
09/25
12/25
Hi-OXSR, NCT06379620: Pilot Open Label Use of the for the Treatment of Post COVID-19 Cognitive Dysfunction

Completed
1
37
Canada
Hi-OxSR Sequential Rebreathing mask (oxygen concentrator)
University Health Network, Toronto
Post COVID-19 Condition
03/24
03/24
NCT05231668: Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Terminated
1
16
Europe, Canada, US, RoW
SAR439459, Placebo
Sanofi
Osteogenesis Imperfecta
11/24
11/24
NCT01155245: Teriparatide (PTH) and Bone Strength in Postmenopausal Women

Active, not recruiting
N/A
60
Canada
Forteo
University Health Network, Toronto, Eli Lilly and Company
Osteoporosis
01/24
01/25
NCT01747304: Evaluation of IVA (SE Femur Scans) to Identify Incomplete AFFs

Recruiting
N/A
500
Canada
DXA Se femur scans (previously called IVA femur), SF Femur scans
University Health Network, Toronto
Atypical Femur Fracture
12/24
12/25
NCT01155232: Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis

Recruiting
N/A
100
Canada
Teriparatide, Teriparatide is a section of the parathyroid hormone (PTH) given by injection., The drug is marketed by Eli Lilly under the name of Forteo
University Health Network, Toronto
Osteoporosis
01/25
01/26
NCT01747291: Atypical Fracture Cohort Study

Recruiting
N/A
300
Canada
University Health Network, Toronto
Atypical Femur Fracture, Atypical Subtrochanteric Fracture, Osteoporosis With AFf
12/25
12/26
NCT04110795: Personalizing Osteoporosis Care: Clinical & Genetic Risk Factors for AFFs

Active, not recruiting
N/A
1200
Canada
No Intervention
University Health Network, Toronto, Canadian Institutes of Health Research (CIHR)
Atypical Femur Fracture
12/25
12/27
NCT05541432: Finding the Optimal Resistance Training Intensity For Your Bones

Recruiting
N/A
324
Canada
Supervised strength training (group 1), Supervised strength training (group 2), Home exercise
University of Waterloo, Canadian Institutes of Health Research (CIHR), University of Saskatchewan, University Health Network, Toronto
Osteoporosis, Osteopenia
09/26
09/26
CaNAL, NCT03569826: Canadian Network for Autoimmune Liver Disease

Recruiting
N/A
2500
Canada
Observational; no intervention
University Health Network, Toronto
Primary Bilary Cirrhosis (PBC), Autoimmune Hepatitis, Overlap Syndrome
12/28
12/28
Angel, Jonathan B
CINNAMON, NCT06039579: Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

Completed
2
44
Europe, Canada, US, RoW
VH4004280, VH4011499, VH4004280 Matching Placebo, VH4011499 Matching Placebo
ViiV Healthcare
HIV Infections
06/24
06/24
Cameron, William
NCT04773665: Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

Completed
1
114
Canada
VBI-2902a, Placebo, VBI-2905a
VBI Vaccines Inc.
Covid19
11/22
11/22
NCT05548439: Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

Active, not recruiting
1
103
Canada
VBI-2901a
VBI Vaccines Inc.
COVID-19, Coronavirus Infections
02/24
02/24
NCT05614245: Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant

Withdrawn
1
60
Canada
VBI-2901e
VBI Vaccines Inc.
COVID-19, Coronavirus Infections
06/24
06/24
Stiell, Ian
RAFF4, NCT04485195: Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

Recruiting
4
340
Canada
Vernakalant, BRINAVESS, Procainamide
Ottawa Hospital Research Institute
Atrial Fibrillation
09/23
06/24
RAFF5, NCT05468281: Proposal: Improve the Quality and Safety of Patients Seen in the Emergency Department for Acute Atrial Fibrillation and Flutter

Completed
N/A
1108
Canada
Checklist implementation
Ottawa Hospital Research Institute
Atrial Fibrillation, Atrial Flutter
07/23
07/23
Knoll, Greg A
NCT03206801: Urine CXCL10 Monitoring Trial in Kidney Transplant

Active, not recruiting
2/3
420
Canada, RoW
Kidney transplant biopsy, Protocol biopsy
University of Manitoba, Canadian Institutes of Health Research (CIHR), Canadian National Transplant Research Program
Kidney Transplant; Complications, Rejection of Renal Transplant
06/24
09/25
CARSK, NCT03674307: Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

Recruiting
N/A
3306
Europe, Canada, US
No screening, Regular Screening
University of British Columbia, University of Sydney
Cardiovascular Diseases, End Stage Renal Disease, Kidney Transplantation, Dialysis Related Complication
12/25
12/25
Patel, Rakesh
NCT04511702: Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate

Completed
4
191
US
Pegloticase with MTX, Methotrexate
Amgen
Chronic Uncontrolled Gout, Gout, Uncontrolled Gout
01/24
03/24
TOGETHER-PsA, NCT06588296: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

Recruiting
3
250
US
Ixekizumab, LY2439821, Tirzepatide, LY3298176
Eli Lilly and Company
Psoriatic Arthritis, Obesity
04/26
08/26
TOPAZ-1, NCT04895241 / 2020-005775-12: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Checkmark Trial initiation of TOPAZ-1 trial in lupus
Jun 2021 - Jun 2021: Trial initiation of TOPAZ-1 trial in lupus
Recruiting
3
540
Europe, US, RoW
Litifilimab, BIIB059, Placebo
Biogen
Lupus Erythematosus, Systemic
09/26
03/27
NEPTUNUS-2, NCT05349214 / 2021-005687-22: Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

Active, not recruiting
3
505
Europe, Canada, Japan, US, RoW
VAY736, Placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Sjogren Syndrome
05/25
05/27
NCT06104124: A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Recruiting
3
621
Europe, Canada, Japan, US, RoW
Dazodalibep, VIB 4920, MEDI 4920, Placebo
Amgen
Sjogren's Syndrome
08/26
08/26
NEPTUNUS-Ext, NCT05985915: A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Recruiting
3
600
Europe, Canada, Japan, US, RoW
Ianalumab (VAY736), VAY736, Placebo
Novartis Pharmaceuticals
Sjogrens Syndrome
08/28
07/30
NCT05848258: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

Recruiting
2
380
Europe, US, RoW
LY3871801, Placebo
Eli Lilly and Company, Rigel Pharmaceuticals
Rheumatoid Arthritis
02/26
07/26
NCT02926924: Prophylactic Application of an Incisional Wound Vac to Prevent Wound Complications in Obese Spine Surgery Patients

Recruiting
N/A
150
US
Wound Vac, Negative pressure therapy, Standard Dressing
University of Michigan
Spine Surgery, Wounds Vac
04/23
04/23
NCT06217380: Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program

Terminated
N/A
10
Canada
Masimo SafetyNet Alert (MSNA)
Masimo Corporation
Opioid Use
02/24
02/24
JULI, NCT04726254: The Registry--Hemp and Cannabis Observational Registry

Recruiting
N/A
2000
US
Juva Life, Targeted Medical Education
Chronic Pain, Appetite Disorders, Neuropathy, Menopausal Syndrome, Anxiety, Sleep Disturbance, Nausea
02/24
02/25

Recruiting
N/A
3000
US
Treatment Recommendation Surveys, 7-gene biosignature
PreludeDx, University of South Florida
DCIS
12/25
12/35
NA-PAS, NCT04836546: Eversense® Non-adjunctive Use Post Approval Study

Recruiting
N/A
925
US
Blood glucose meter, Eversense CGM System
Senseonics, Inc.
Diabetes
03/26
03/26
RISC, NCT05848856: The Registry--Risk Informed Screening Registry

Not yet recruiting
N/A
10000
US
Breast Cancer, Cardiometabolic, Cardiovascular Risk Screening and Follow up
Precision Health Equity Initiative
Breast Cancer Risk, Cardiovascular Disease Risk, Cardiometabolic Risk, Diabetes
09/34
09/35
Kim, Paul R
NCT03102125: Allograft Dysfunction in Heart Transplant

Recruiting
4
376
US
Regadenoson, Lexiscan
Paul Kim
Heart Transplant Failure and Rejection
12/25
12/25
PE-TRACT, NCT05591118: Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Recruiting
3
500
US
Anticoagulant Therapy, Catheter-Directed Therapy
NYU Langone Health, National Heart, Lung, and Blood Institute (NHLBI)
Pulmonary Embolism
01/27
01/28
NCT05417074: Assessing SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Not yet recruiting
2
10
US
Placebo, SLS-002, Intranasal Racemic Ketamine, Standard of care
Johns Hopkins University, Seelos Therapeutics, Inc.
Depression, Suicidal Behavior, Suicidal Ideation
03/23
08/23
ELIMINATE, NCT05488340: A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli ( Trial)

Recruiting
2
318
US
LBP-EC01 0.1 x IV dose, 1x10^11 PFU IV dose, LBP-EC01 0.01x IV Dose, 1x10^10 PFU IV Dose, LBP-EC01 IV Infusion Dose, 1x10^12 PFU IV Infusion Dose, Placebo, LBP-EC01, TMP/SMX
Locus Biosciences, Parexel
Urinary Tract Infections
06/25
12/25
NCT03543007: Evaluating the Safety and Efficacy of GrafixPL™PRIME for the Treatment of Chronic Venous Leg Ulcers

Not yet recruiting
N/A
30
US
GrafixPL™ PRIME plus standard compression therapy, standard compression therapy alone
Georgetown University, Osiris Therapeutics
Venous Leg Ulcer, Chronic Leg Ulcer, Venous Insufficiency, Venous Stasis
09/22
01/23
3STLIF, NCT04823858: 3Spine Lumbar Fusion Real World Evidence Study

Recruiting
N/A
200
US
Lumbar Interbody Fusion
3Spine, MCRA
Lumbar Spine Degeneration
05/24
08/26
NCT04684901: Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures

Enrolling by invitation
N/A
50
US
AlloWrap® Amniotic Membrane
AlloSource
Cervical Stenosis, Spondylolisthesis, Cervical Radiculopathy, Cervical Disc Disorder
06/25
01/26
ACES-EMB, NCT06414603: A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

Recruiting
N/A
250
US
The Prospera™ Test
Natera, Inc.
Heart Transplant Failure and Rejection
12/24
12/25
DEFINE-HT, NCT05309382: Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

Completed
N/A
147
US
Prospera
Natera, Inc.
Heart Transplant
10/24
10/24
NCT01420237: Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study

Active, not recruiting
N/A
352
Europe, Canada, US
Restoration ADM X3 Device
Stryker Orthopaedics
Arthroplasty, Replacement, Hip
06/26
06/26
Lapner, Peter
NCT02143245: Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections

Active, not recruiting
N/A
118
Canada
Synovial Biopsy, Open Tissue Biopsy
Ottawa Hospital Research Institute
Total Shoulder Arthroplasty
12/22
12/27
NCT02060227: Approach to Shoulder Instability

Completed
N/A
78
Canada
Open Latarjet procedure, Arthroscopic Bankart repair
Ottawa Hospital Research Institute
Anterior Shoulder Instability
12/23
04/24
TSAvRSA, NCT04228419: TSA vs RSA in Glenohumeral Osteoarthritis

Recruiting
N/A
108
Canada
Total Shoulder Arthroplasty, Reverse Shoulder Arthroplasty
Ottawa Hospital Research Institute
Osteoarthritis of the Shoulder
01/25
12/28
SERVASA15, NCT05487274: TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion

Recruiting
N/A
108
Canada
Total Shoulder Arthroplasty + augmented glenoid component, Reverse Shoulder Arthroplasty
Ottawa Hospital Research Institute
Osteoarthritis Shoulder
03/26
12/29
UESOA, NCT04634773: Unravelling the Etiology of Shoulder Osteoarthritis

Active, not recruiting
N/A
60
Canada
Low-dose CT, T1Rho MRI, Motion Analysis
Ottawa Hospital Research Institute, University of Ottawa
Osteoarthritis of the Shoulder
12/26
12/27
NCT02966886: TSA Techniques in Glenohumeral OA

Recruiting
N/A
216
Canada
Eccentric Reaming, Augmented Glenoid Component Implantation, Posterior Glenoid Bone Grafting
Ottawa Hospital Research Institute
Osteoarthritis, Shoulder
12/27
12/28
Dervin, Geoffrey
NCT03564730: Staged Versus Simultaneous Bilateral Knee Arthroplasty

Active, not recruiting
N/A
224
Canada
Simultaneous Knee Arthroplasty (UKA), Staged Knee Arthroplasty (UKA)
Orthopaedic Innovation Centre
Knee Osteoarthritis
11/25
12/26
NCT00261066: Outcome Following Orthopaedic Surgery

Active, not recruiting
N/A
8439
Canada
Ottawa Hospital Research Institute
Osteoarthritis of Knee
06/26
06/26
Juni, Peter
RECLAIM, NCT05513560: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

Active, not recruiting
2/3
460
Canada
Ibudilast, MN-166, Pentoxifylline, Placebo
University Health Network, Toronto
Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19
03/25
03/25
Tinmouth, Alan
iTADS, NCT03344887: An Innovative Trial Assessing Donor Sex on Recipient Mortality

Active, not recruiting
4
8850
Canada
RBC Transfusion from male donor, RBC Transfusion from female donor
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Canadian Blood Services
Red Blood Cell Transfusion
01/21
12/22
PATH, NCT04448184: Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The III Trial)

Recruiting
3
662
Canada
Tranexamic Acid, SteriMax Inc., Cyclokapron®
Ottawa Hospital Research Institute, Alberta Cancer Foundation
Hematologic Neoplasms
02/27
02/27
Zimmerman, Deborah
NCT03787589: Exercise in Patients With End Stage Kidney Disease

Recruiting
N/A
90
Canada
Exercise Prescription
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR)
Renal Failure
01/25
09/25
Fergusson, Dean
iTADS, NCT03344887: An Innovative Trial Assessing Donor Sex on Recipient Mortality

Active, not recruiting
4
8850
Canada
RBC Transfusion from male donor, RBC Transfusion from female donor
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Canadian Blood Services
Red Blood Cell Transfusion
01/21
12/22
TRACTION, NCT04803747: A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery

Active, not recruiting
4
8440
Canada
Tranexamic acid (TXA), Placebo (0.9 % Saline)
University of Manitoba, Canadian Institutes of Health Research (CIHR), Health Sciences Centre Foundation, Manitoba, The Ottawa Hospital
Major Non-cardiac Surgeries
03/24
10/24
POISE, NCT04871412: The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III

Recruiting
3
20
Canada
Vitamin D3 Drops, Vitamin D, Coriolus Versicolor, Trident SAP 66:33 Lemon, Fish Oil, Probiotic Pro12, Probiotics, Provitalix Pure Whey Protein, Protein Powder, Theracurmin 2X, Curcumin, Green Tea Extract, EGCG, Nutrition Recommendations, Physical Activity Recommendations, Psychological Recommendations
Ottawa Hospital Research Institute, The Canadian College of Naturopathic Medicine, Lotte & John Hecht Memorial Foundation, The Centre for Health Innovation, University of Ottawa
Lung Cancer, Gastric Cancer, Esophageal Cancer
12/29
12/31
CIRCA-19 RCT, NCT04865107: Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial

Recruiting
2
54
Canada
UC-MSCs, Placebo
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR)
Covid19, Acute Respiratory Distress Syndrome
04/22
04/22
HEMOTION, NCT03260478: HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The Trial

Completed
N/A
742
Europe, Canada, RoW
Red Blood Cells Transfusion
CHU de Quebec-Universite Laval, Canadian Critical Care Trials Group, Canadian Traumatic Brain Injury Research Consortium, Canadian Institutes of Health Research (CIHR), Canadian Perioperative Anesthesia Clinical Trials (PACT) Group
Traumatic Brain Injury, Transfusion
10/23
02/24
Aaron, Shawn
APIC, NCT06552364: Air Pollution and Inhaled Corticosteroids in COPD

Not yet recruiting
4
48
NA
LABA+LAMA, Anoro Ellipta, LABA+LAMA+ICS, Trelegy Ellipta, Filtered Air, Diesel Exhaust, Traffic Related Air Pollution
University of British Columbia, University of Calgary, University of Ottawa, University of Manitoba, University of North Carolina, Chapel Hill
COPD
12/26
12/28
CanCOLD, NCT00920348: The Canadian Cohort Obstructive Lung Disease

Active, not recruiting
N/A
1500
Canada
McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR), GlaxoSmithKline, AstraZeneca, Pfizer, Boehringer Ingelheim, Novartis, Takeda, Merck Sharp & Dohme LLC, Almirall, SAS
COPD, Chronic Obstructive Pulmonary Disease
12/22
12/22
NCT05181670: The Canadian Respiratory Research Network Long COVID-19 Study

Enrolling by invitation
N/A
650
Canada
Sunnybrook Health Sciences Centre, Canadian Institutes of Health Research (CIHR)
SARS-CoV-2 Infection, Post-acute Sequelae of SARS-CoV-2
08/24
12/24
ISAR, NCT04045587: International Severe Asthma Registry: Canadian Cohort

Recruiting
N/A
714
Canada
University of British Columbia, University of Alberta, University of Toronto, Laval University, McGill University, Université de Sherbrooke, The Ottawa Hospital, Queen's University, University of Saskatchewan, Western University, Canada
Severe Asthma
12/27
12/28
UCAP2, NCT06392776: Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL

Recruiting
N/A
420
Canada
Early diagnosis and treatment
Ottawa Hospital Research Institute
COPD, Asthma
12/28
12/29
CLOUD, NCT06819969: The Canadian Lung Outcomes in Users of Vaping Devices Study

Not yet recruiting
N/A
500
Canada
University of British Columbia, BC Children's Hospital Research Institute, Providence Healthcare, British Columbia Cancer Agency, University of Alberta, McMaster University, University of Ottawa, Université de Sherbrooke, University of Toronto
Small Airways Diseases, Vaping, Vaping Related Disorder, Vaping Teens, Vaping Behavior
12/29
12/29
NCT05204888: MyAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Recruiting
N/A
642
Canada, US
myAirvo3, Pulse oximeter
Temple University, Fisher and Paykel Healthcare
COPD
01/27
03/27
NCT06014840: The UCAP 2 Pilot Study

Withdrawn
N/A
200
Canada
Assessment and Treatment provided to participant by a respirologist using evidence-based guidelines for asthma or COPD
Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR)
COPD, Asthma
12/27
12/28
Vaillancourt, Christian
EpiDOSE, NCT03826524: Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Recruiting
4
3790
Canada
Epinephrine, Adrenaline
Unity Health Toronto, Canadian Institutes of Health Research (CIHR), Pfizer
Cardiac Arrest, Out-Of-Hospital, Sudden Cardiac Arrest, Ventricular Fibrillation, Ventricular Tachycardia-Pulseless
12/27
06/28
NCT03642587: Canadian Sudden Cardiac Arrest Network

Completed
N/A
82054
Canada
There is no intervention in this study.
Unity Health Toronto, University of Toronto, Sunnybrook Health Sciences Centre, Ottawa Hospital Research Institute, University of British Columbia, Providence Health & Services, McMaster University, Queen's University, Kingston, Ontario, Institute for Clinical Evaluative Sciences, Alberta Health services, University of Saskatchewan, Dalhousie University, University of Prince Edward Island, Memorial University of Newfoundland
Sudden Cardiac Death, Sudden Cardiac Arrest
03/23
06/23
NCT03894059: An Educational Program to Improve Cardiac Arrest Diagnostic Accuracy of Ambulance Telecommunicators

Active, not recruiting
N/A
12224
Canada
Educational Intervention
Ottawa Hospital Research Institute, Ontario Ministry of Health and Long Term Care, BC Emergency Health Services, Medacom Atlantic, Alberta Health services, Emergency Health Services Nova Scotia, Health PEI, Providence Health Care, British Columbia
Heart Arrest, Heart Arrest, Out-Of-Hospital, Cardiac Arrest, Death, Sudden, Cardiac, Cardiac Arrest, Sudden, Cardiopulmonary Arrest
12/25
12/25
Harrison, Denise
NCT00404898: NYU/Bellevue WTC Health Impacts Research Registry

Recruiting
N/A
16000
US
NYU Langone Health, National Institute for Occupational Safety and Health (NIOSH/CDC)
Exposure to World Trade Center Dust
09/26
09/26
Torres, Carlos
NCT05532787: Comparison of Accelerated Diagnostic Pathways for Acute Chest Pain in Emergency Departments in the United Arab Emirates

Recruiting
N/A
1200
RoW
Application of acute chest pain risk stratification scores (HEART and EDACS)
Zayed Military Hospital
Acute Coronary Syndrome, Chest Pain
02/23
03/23
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Completed
N/A
244
US
MiniMed 780G System
Medtronic Diabetes, Eli Lilly and Company
Type 1 Diabetes
01/24
01/24
NCT05224258: Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Completed
N/A
240
Canada, US, RoW
MiniMed 780G System
Medtronic Diabetes
Type 1 Diabetes
06/24
06/24
Ryan, Stephen E
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
BRIDGE, NCT05538663: Intravesical BCG vs GEMDOCE in NMIBC

Recruiting
3
870
US
Gemcitabine, GEMZAR, Docetaxel, Taxotere, Bacillus Calmette Guerin, BCG
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Non-muscle-invasive Bladder Cancer
11/29
10/30
StrokeVIS, NCT05809973: The Oslo Study of Visual Impairment After Stroke

Recruiting
N/A
120
Europe
VISA tool
Oslo University Hospital, University of Liverpool, University of South-Eastern Norway
Stroke, Acute
05/24
12/24

Recruiting
N/A
348
Europe, Canada, US, RoW
Embolization
Maastricht University
Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR)
06/26
06/29
Smith, Heather
ATS22, NCT04378790: A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Recruiting
3
544
US
Patching, Eye Patch, Glasses, Spectacles
Jaeb Center for Health Research, National Eye Institute (NEI), Pediatric Eye Disease Investigator Group
Amblyopia
05/28
05/28
WATCH, NCT04869774: Wound And Symptom Tracking After Colorectal Surgery Using How2trak

Not yet recruiting
N/A
80
NA
How2Trak mobile application
University of Ottawa, The Ottawa Hospital, Health Outcomes Worldwide
Surgical Site Infection, Mobile Applications, Surgery--Complications, Colorectal Surgery
11/21
02/22
 

Download Options